Dr Carmine Gentile, PharmD/PhD, FAHA, is a senior lecturer within the School of Biomedical Engineering at the University of Technology Sydney (UTS) and leads the Cardiovascular Regeneration Group both at UTS and at the University of Sydney. He received his BSc, MSc and PharmD degrees at the University of Pisa, Italy, and his PhD at the Medical University of South Carolina, Charleston, SC, USA, funded by a prestigious American Heart Association Fellowship. Since 2013, Dr Gentile has worked in Australia at the Heart Research Institute, University of Sydney, and now at UTS, supported by several awards and grants, working within a multidisciplinary team with scientists, industry partners and clinicians to quickly translate his findings from bench to bedside. Dr Gentile is an internationally recognised expert in the field of 3D bioprinting and stem cell technologies, and his more recent studies focus on novel molecular and cellular approaches to treat cardio-vascular disease, including myocardial infarction and heart failure. These studies are based on the use of the “mini-hearts” he developed as “bioinks” for human heart tissues. In 2016, he was invited as visiting research fellow at Harvard Medical School, where he worked towards novel in vitro models using mini-hearts to study human heart physiology.
Dr Carmine Gentile, PharmD/PhD, FAHA, is a senior lecturer within the School of Biomedical Engineering at the University of Technology Sydney (UTS) and leads the Cardiovascular Regeneration Group both at UTS and at the University of Sydney. He received his BSc, MSc and PharmD degrees at the University of Pisa, Italy, and his PhD at the Medical University of South Carolina, Charleston, SC, USA, funded by a prestigious American Heart Association Fellowship. Since 2013, Dr Gentile has worked in Australia at the Heart Research Institute, University of Sydney, and now at UTS, supported by several awards and grants, working within a multidisciplinary team with scientists, industry partners and clinicians to quickly translate his findings from bench to bedside. Dr Gentile is an internationally recognised expert in the field of 3D bioprinting and stem cell technologies, and his more recent studies focus on novel molecular and cellular approaches to treat cardio-vascular disease, including myocardial infarction and heart failure. These studies are based on the use of the “mini-hearts” he developed as “bioinks” for human heart tissues. In 2016, he was invited as visiting research fellow at Harvard Medical School, where he worked towards novel in vitro models using mini-hearts to study human heart physiology.